Andrew Judge, PhD, was highlighted in a recent International Innovation article. The piece explores his skeletal muscle atrophy research. Judge discusses his research team’s investigation of molecular signaling pathways which lead to skeletal muscle atrophy, and his projects focused on understanding the forkhead boxO pathway – a key determinant of muscle wasting in multiple conditions. Focus on this topic could ultimately lead to novel treatments and therapies aimed at reducing muscle wasting and improving the survival rates and quality of life for individuals who face muscle wasting diseases, aging, and sedentary lifestyles.